logo

Copart Hits Appreciation Target
By: Bobs Advice for Stocks   Thursday, May 29, 2008 7:31 PM

Vote for next session
The next market session will close:

Earlier this morning, my Copart (CPRT) stock hit an appreciation target of a 30% gain triggering a partial sale of 1/7th of my position or 30 shares which were sold at $43.80/share.  This represented a gain of $10.08/share or 29.9% since purchase.  The shares were initially acquired 9/27/07 at a cost basis of $33.72/share.

As you may know, I use sales like today's sale as a 'signal' to buy an additional position if I am under my maximum of 20 positions.  Since, after yesterday's sale of ResMed (RMD), I am at my minimum of 5 positions, well under my maximum, this sale indeed did give me a 'permission slip' to be buying a new position. 

A few moments ago I purchased 70 shares of Visa (V) as that new position.  I shall be writing this up a little later. 

Even though I have sold shares of Copart (CPRT), with the company's solid second quarter results (even though they did miss expectations) and their strong Morningstar.com '5-Yr Restated' financials,

COPART (CPRT) IS RATED A BUY

When would I sell shares next and how many?  Well on the upside, my next sale point would be at a 60% appreciation target which with the cost basis being at $33.42, this would work out to 1.6 x $33.42 = $53.47.  At that time, my plan would be to sell 1/7th of the remaining shares which now at 180 shares would be 180/7 = 25 shares. 

On the downside, after a single sale (at the 30% appreciation level) I move my sale point up from an (8)% loss to break-even, or in this case would mean selling all of my remaining 180 shares if the stock should decline to $33.42.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Bobs Advice for Stocks



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia